The on-target efficiency of Alt-R S.p. HiFi Cas9 Nuclease V3 is typically 90–100% of the standard Alt-R S.p. Cas9 Nuclease V3 efficiency at a specific target site.
The efficiency of both nucleases varies based upon the target site, cell type, and experimental conditions.
*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.